151 related articles for article (PubMed ID: 35782332)
1. SENP1 Aberrance and Its Linkage to Clinical Features, Adjuvant Regimen, and Prognosis in Patients With Surgical Non-small Cell Lung Cancer Receiving Adjuvant Chemotherapy.
Yang Q; Yang M; Zhang J; Ma Y
Front Surg; 2021; 8():771785. PubMed ID: 35782332
[TBL] [Abstract][Full Text] [Related]
2. Small ubiquitin-like modifier/sentrin-specific peptidase 1 associates with chemotherapy and is a risk factor for poor prognosis of non-small cell lung cancer.
Liu K; Zhang J; Wang H
J Clin Lab Anal; 2018 Nov; 32(9):e22611. PubMed ID: 30043429
[TBL] [Abstract][Full Text] [Related]
3. Over-expression of small ubiquitin-like modifier proteases 1 predicts chemo-sensitivity and poor survival in non-small cell lung cancer.
Mu J; Zuo Y; Yang W; Chen Z; Liu Z; Tu J; Li Y; Yuan Z; Cheng J; He J
Chin Med J (Engl); 2014; 127(23):4060-5. PubMed ID: 25430449
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of circulating CDC42 and its correlation with demographic characteristics, comorbidities, tumor features, chemotherapeutic regimen and survival profile in non-small-cell lung cancer patients.
Yan J; Wan D
J Clin Lab Anal; 2022 Feb; 36(2):e24140. PubMed ID: 34952984
[TBL] [Abstract][Full Text] [Related]
5. Dysregulated transient receptor potential channel 1 expression and its correlation with clinical features and survival profile in surgical non-small-cell lung cancer patients.
Ke C; Long S
J Clin Lab Anal; 2022 Mar; 36(3):e24229. PubMed ID: 35106847
[TBL] [Abstract][Full Text] [Related]
6. High-mobility group box 2 reflects exacerbated disease characteristics and poor prognosis in non-small cell lung cancer patients.
Lou N; Zhu T; Qin D; Tian J; Liu J
Ir J Med Sci; 2022 Feb; 191(1):155-162. PubMed ID: 33635447
[TBL] [Abstract][Full Text] [Related]
7. Plasma Exosome-Derived Sentrin SUMO-Specific Protease 1: A Prognostic Biomarker in Patients With Osteosarcoma.
Wang L; Wu J; Song S; Chen H; Hu Y; Xu B; Liu J
Front Oncol; 2021; 11():625109. PubMed ID: 33791211
[TBL] [Abstract][Full Text] [Related]
8. The preoperative hemoglobin, albumin, lymphocyte, and platelet score is a prognostic factor for non-small cell lung cancer patients undergoing adjuvant chemotherapy: a retrospective study.
Wei S; Shao J; Wang J; Wang G
Ann Transl Med; 2022 Apr; 10(8):457. PubMed ID: 35571436
[TBL] [Abstract][Full Text] [Related]
9. Blood regulator of G protein signalling 1 as a potential prognostic biomarker in surgical nonsmall cell lung cancer patients: Correlation with clinical features and survival.
Wang L; Zhang H; Gu X; Wang Y
Clin Respir J; 2024 Jan; 18(1):e13712. PubMed ID: 38081176
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA_0001946 is insufficiently expressed in tumor tissues, while its higher expression correlates with less lymph node metastasis, lower TNM stage, and improved prognosis in NSCLC patients.
Zhang M; Wen F; Zhao K
J Clin Lab Anal; 2021 Aug; 35(8):e23625. PubMed ID: 34216509
[TBL] [Abstract][Full Text] [Related]
11. Topoisomerase II alpha expression and the benefit of adjuvant chemotherapy for postoperative patients with non-small cell lung cancer.
Yan S; Shun-Chang J; Li C; Jie L; Ya-Li L; Ling-Xiong W
BMC Cancer; 2010 Nov; 10():621. PubMed ID: 21067592
[TBL] [Abstract][Full Text] [Related]
12. Chaperonin-containing tailless complex polypeptide 1 subunit 6A links with aggravating tumor features and disease-free survival in surgical gastric cancer patients: A long-term follow-up study.
He T; Yu D; Wang Z; Guo C; Chang Y; Wang D
Clin Res Hepatol Gastroenterol; 2022; 46(7):101913. PubMed ID: 35346891
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of SUMO-specific protease 1 (SENP1) in prostate cancer patients undergoing radical prostatectomy.
Li T; Huang S; Dong M; Gui Y; Wu D
Urol Oncol; 2013 Nov; 31(8):1539-45. PubMed ID: 23089540
[TBL] [Abstract][Full Text] [Related]
14. Clinical implication of aquaporin 9 in non-small cell lung cancer patients: its expression and relationship with clinical features and prognosis.
Chen P; Li Q; Zhou Y; Lu H; Chen H; Qian M; Chen J
Ir J Med Sci; 2022 Apr; 191(2):651-658. PubMed ID: 33759071
[TBL] [Abstract][Full Text] [Related]
15. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
[TBL] [Abstract][Full Text] [Related]
16. Katanin P80 correlates with larger tumor size, lymph node metastasis, and advanced TNM stage and predicts poor prognosis in non-small-cell lung cancer patients.
Ye Q; Zhang M; Yin Y
J Clin Lab Anal; 2020 Apr; 34(4):e23141. PubMed ID: 31944409
[TBL] [Abstract][Full Text] [Related]
17. The Prognostic Effect of MAC30 Expression on Patients With Non-Small Cell Lung Cancer Receiving Adjuvant Chemotherapy.
Ding H; Gui X; Lin X; Chen R; Ma T; Sheng Y; Cai H; Fen Y
Technol Cancer Res Treat; 2017 Oct; 16(5):645-653. PubMed ID: 27688262
[TBL] [Abstract][Full Text] [Related]
18. Potentiality of forkhead box Q1 as a biomarker for monitoring tumor features and predicting prognosis in non-small cell lung cancer.
Li L; Xu B; Zhang H; Wu J; Song Q; Yu J
J Clin Lab Anal; 2020 Jan; 34(1):e23031. PubMed ID: 31713908
[TBL] [Abstract][Full Text] [Related]
19. Relationship between circulating lung-specific X protein messenger ribonucleic acid expression and micrometastasis and prognosis in patients with early-stage nonsmall cell lung cancer.
Cui Y; Wang W; Yao S; Qiu Z; Cong L
J Cancer Res Ther; 2020; 16(7):1641-1647. PubMed ID: 33565511
[TBL] [Abstract][Full Text] [Related]
20. Value of circular RNA 0007385 in disease monitoring and prognosis estimation in non-small-cell lung cancer patients.
Lin Y; Su W; Lan G
J Clin Lab Anal; 2020 Aug; 34(8):e23338. PubMed ID: 32666646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]